跳至主要内容
临床试验/NCT04007341
NCT04007341已完成不适用

Effect of Dexmedetomidine on the Inflammatory Response in Patients Undergoing Lung Resection Surgery

Seoul St. Mary's Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年7月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Interleukin (IL)-6

研究概览

简要总结

The postoperative inflammatory response is significant in lung resection surgery because of major operation and one-lung ventilation. Dexmedetomidine has been shown to reduce pro-inflammatory cytokine levels and improve clinical outcomes. The aim of this study was to determine the effects of dexmedetomidine on inflammatory responses after lung resection surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective video-assisted thoracoscopic surgery (VATS) lobectomy
  • 20 < age < 75
  • American Society of Anesthesiologists (ASA) classification I~II

排除标准

  • preoperative inflammation (CRP>10ng/#, WBC>10,000/mm3, body temperature >38#)
  • steroid administration within 1 month
  • hematologic / autoimmune disease
  • congestive heart failure (NYHA class III~IV) or significant arrhythmia
  • severe obstructive / restrictive pulmonary disease
  • previous history of thoracic surgery

研究组 & 干预措施

Dexmedetomidine group

Experimental

Patients in the dexmedetomidine group were infused with a loading dose of dexmedetomidine (1.0 mcg/kg over 10 min) and were thereafter infused at a rate of 0.5 mg/kg/h.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Interleukin (IL)-6

时间窗: 24 hours after surgery

Blood samples were collected from the antecubital vein

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wonjung Hwang

Assistant professor

Seoul St. Mary's Hospital

研究点 (1)

Loading locations...

相似试验